Publications by authors named "A J Lenaerts"

Article Synopsis
  • Scientists created new medicines called spectinamides to help treat tuberculosis (TB) more effectively.
  • One of these, named MBX-4888A, works well with other TB drugs like rifampin and pyrazinamide in mice.
  • The research showed that using MBX-4888A can help shorten the treatment time for TB and seems to be safe for long-term use in mice.
View Article and Find Full Text PDF

Spectinamides are a novel class of narrow-spectrum antitubercular agents with the potential to treat drug-resistant tuberculosis infections. Spectinamide 1810 has shown a good safety record following subcutaneous injection in mice or infusion in rats but exhibits transient acute toxicity following bolus administration in either species. To improve the therapeutic index of 1810, an injectable prodrug strategy was explored.

View Article and Find Full Text PDF
Article Synopsis
  • Spectinamides are new medicines that help fight TB (tuberculosis), modified to work better in the body.
  • In studies with mice, one type called MBX-4888A showed it could improve treatment when used with other TB drugs.
  • This research tested how well it works in different mouse models, showing it's safe and might help cure TB faster.
View Article and Find Full Text PDF

Rivers are increasingly used as superhighways for the continental-scale transportation of freight goods, but the ecological impact of large vessel traffic on river ecosystems is difficult to study. Recently, the temporary maintenance closure of lock and dam systems on the Illinois Waterway (USA) brought commercial vessel traffic to a halt along the river's length, offering a rare opportunity to study the response of the ecosystem before, during, and after an extended pause of this persistent anthropogenic disturbance. We observed improvements in main- and side-channel water quality and a redistribution of fish habitat-use during a months-long, near-complete reduction of large vessel traffic.

View Article and Find Full Text PDF

Linezolid is a drug with proven human antitubercular activity whose use is limited to highly drug-resistant patients because of its toxicity. This toxicity is related to its mechanism of action─linezolid inhibits protein synthesis in both bacteria and eukaryotic mitochondria. A highly selective and potent series of oxazolidinones, bearing a 5-aminomethyl moiety (in place of the typical 5-acetamidomethyl moiety of linezolid), was identified.

View Article and Find Full Text PDF